Skip to content

Capecitabine

Capecitabine appears in one listed tablet, Zocitab. This antineoplastic medicine has recorded uses for metastatic breast cancer and colorectal cancer. The product’s strength, formulation and directions define its place within an individual cancer treatment plan. Listed products differ in ingredient profile, form, strength, and pack size.

Zocitab

Metastatic Breast Cancer, Colorectal Cancer

500mg

Formulated to alleviate neoplastic cellular growth to support cancer remission and target tumour cell proliferation.

From$13.62/ tabletView

How does capecitabine work?

The active ingredient Capecitabine is converted in the body to fluorouracil, which disrupts DNA production in rapidly dividing cells. Zocitab addresses Metastatic Breast Cancer and Colorectal Cancer within Oncology Support.

Important safety information for Capecitabine

Information about Capecitabine on this page is an educational overview, not medical advice. Products can differ in formulation, strength, and directions, and this content does not authorise clinical application or unsupervised use. Review the labelling for each product and speak with a healthcare professional whenever clinical judgement is needed. Product-specific contraindications, interactions, and reactions should be checked in the product labelling and verified clinical sources.